Skip to content
sellWeak cluster of 4

DST Capital LLC sold $14k of HRGN

owner at Harvard Apparatus Regenerative Technology, Inc.. 1,952 shares at an average of $7.17, traded Dec 7, 2022, filed Dec 9, 2022.

Warning score
27
Value
$14k
1,952 shares
Holdings after
3,663,325
-0% from before
From 52-week low
+215%
low $2.30, close $7.25
From 52-week high
0%
high $7.25, as of Dec 7, 2022

Score components

  • Role
    10% owner
    +12
  • Trade size
    $14k at market
    0
  • Share of holdings sold
    Sold 0.1% of holdings
    0
  • Cluster
    4 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

HRGNOct 14, 2026 · close 2.25
Since filing Dec 9, 2022: -67.4%SPY +106.1% · excess -173.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001415889-22-012350, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 7, 2022XIn-the-money exercise
Common Stock
+7,000$2.00$14k3,665,277Dec 9, 2022
Dec 7, 2022SOpen-market sale
Common Stock
-1,952$7.17$14k3,663,325Dec 9, 2022
Dec 7, 2022XIn-the-money exercise
Warrants (right to buy)derivative
-7,000$0.00$00Dec 9, 2022

Related signals

Other insiders at Harvard Apparatus Regenerative Technology, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
47Moderate
HRGNbuy
Harvard Apparatus Regenerative Technology, Inc.
Junli He
CEO
$394k
368,630 shares
+38%
38Weak
HRGNbuy
Harvard Apparatus Regenerative Technology, Inc.
Junli He
CEO
$5,100
3,000 shares
+1%
33Weak
HRGNbuy
Harvard Apparatus Regenerative Technology, Inc.
Junli He
CEO
$594
300 shares
+0%
38Weak
HRGNbuy
Harvard Apparatus Regenerative Technology, Inc.
Junli He
CEO
$21k
11,225 shares
+4%
33Weak
HRGNbuy
Harvard Apparatus Regenerative Technology, Inc.
Junli He
CEO
$6,966
4,050 shares
+2%
20Weak
HRGNbuy
Harvard Apparatus Regenerative Technology, Inc.
Junli He
CEO
$6,598
2,299 shares
+1%
33Weak
HRGNbuy
Harvard Apparatus Regenerative Technology, Inc.
Junli He
CEO
$17k
5,101 shares
+2%
23Weak
HRGNbuy
Harvard Apparatus Regenerative Technology, Inc.
Junli He
CEO
$4,480
1,600 shares
+1%
29Weak
HRGNbuy
Harvard Apparatus Regenerative Technology, Inc.
Junli He
CEO
$13k
2,700 shares
+1%
24Weak
HRGNbuy
Harvard Apparatus Regenerative Technology, Inc.
Junli He
CEO
$4,428
900 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

DST Capital LLC sold $14k of HRGN | InsiderTell